1. Introduction {#s0005}
===============

Long QT syndrome (LQTS) is an electric disorder of the heart that predisposes patients to arrhythmias and sudden cardiac death. The arrhythmias related to LQTS are distinctive ventricular arrhythmias called Torsades de Pointes (TdP) [@bb0005]. LQTS type 1 (LQT1) is the most prevalent subtype of the disease. It is caused by mutations in *KCNQ1* gene encoding the α-subunit of the channel responsible for the slow component of the delayed rectifier potassium current (I~Ks~) [@bb0010], [@bb0015]. The inadequate I~Ks~ current leads to prolongation of repolarization time of action potentials (APs) in single CMs and to prolonged QT interval seen in electrocardiogram (ECG). Various mutations in *KCNQ1* have been identified to cause LQT1 possibly with varying clinical phenotypes [@bb0020], [@bb0025].

Currently different LQTS subtypes are diagnosed with gene mutations in particular genes. However, there is a huge spectrum of mutations in each gene and the severity of the disease has been observed to be more dramatic due to mutations in some genetic regions compared to others [@bb0020], [@bb0030]. Also in cell culture studies with transfected cells, different mutations in the same gene have had different effects on the electrical properties of the cells [@bb0035], [@bb0040]. While some mutations (*e.g.* G589D) seem to have rather mild and recessive effect on the I~Ks~ current [@bb0040], other mutations (*e.g.* ivs7-2A \> G) cause a complete loss-of-function of the I~Ks~ channel in a dominant negative fashion [@bb0035]. Little is known about the mechanisms of the ivs7-2A \> G to cause the loss-of-function effect on I~Ks~ current while G589D mutation seems to be a clear trafficking mutation with normal functioning of the channel but with hindered transportation to the plasma membrane [@bb0045].

With induced pluripotent stem cell (iPSC) technology, it is possible to generate genetically defined stem cell lines [@bb0050], [@bb0055] and differentiate these into any cell type of interest. Thereby, *e.g.* LQTS-specific CMs can be generated and studied *in vitro* [@bb0060], [@bb0065], [@bb0070], [@bb0075], [@bb0080], [@bb0085], [@bb0090]. Traditionally the functionality of CMs in cell culture is determined by electrical or optical analysis, such as patch clamp-technique and microelectrode array (MEA) or calcium (Ca^2 +^)-imaging and voltage sensitive probes. However, all these methods have some limitations. Patch clamp-technique is time consuming as well as invasive and cells die after measurements. Voltage sensitive dyes and the tracers used in Ca^2 +^-imaging may alter the electrophysiological properties of CMs and the cells may also be damaged by photo-toxicity [@bb0095] or compartmentalization [@bb0100] and cells die after analysis. MEA can efficiently be used for cell clusters but due to the physical dimensions of the electrodes and limitations in the sensitivity, it is not suitable with single cells. In addition, these methods detect only ion fluxes that obviously are important but some other, currently even unknown factors influencing the beating of CMs may be neglected. The analysis of mechanical beating properties could reveal additional information beyond the electrical phenomena and this analysis is neither invasive nor toxic and cells can be monitored for a long time.

In this study we present the electromechanical properties of LQT1-CMs having different mutations in the *KCNQ1* gene (G589D or ivs7-2A\>G). The electrical and mechanical behavior of the cells was analyzed using a single cell current clamp, Ca^2 +^-imaging and light microscopy video-image analysis. CMs with either of the LQT1-genotypes had significantly prolonged APs, but only CMs with G589D mutation had spontaneous early afterdepolarizations (EADs) at baseline. Additionally, also abnormal Ca^2 +^ transients were observed in LQT1-CMs. We also demonstrate that the mechanical beating behavior of the CMs with different *KCNQ1* genotypes has distinct mutation-specific features. This is the first published work where mechanical beating properties of LQTS are studied at the single cell level and the first evidence that LQTS can be detected by monitoring the mechanical beating of the cells.

2. Methods {#s0010}
==========

The study was approved by the ethical committee of Pirkanmaa Hospital District (R08070) and written consent was obtained from all fibroblast donors.

2.1. Clinical information {#s0030}
-------------------------

LQT1 patient carrying G589D mutation is a 46-year-old female with corrected QT interval (QTc) of 464 ms. She has been suffering from syncopal spells. The other LQT1 patient is a 51-year-old female carrying ivs7-2A\>G in *KCNQ1*. She has suffered from dizziness, darkening of vision and episodes of unconsciousness. Her QTc is 489 ms. Both of these patient are on β-blocker medication. Control iPSCs were generated from a healthy female, 55 years of age with QTc of 406 ms. The patients with LQT1 were on beta blockers and no irregularities in the QTc were found in the resting condition ([Fig. 3](#f0015){ref-type="fig"} A--C).

2.2. Cell culture conditions {#s0035}
----------------------------

Primary fibroblasts from the skin biopsy were cultured under fibroblast culturing conditions using Dulbecco\'s modified Eagle medium (DMEM, Lonza, Basel, Switzerland) with 10% FBS (Lonza), 2 mM glutamax (Life Technologies Ltd, Paisley, UK) and 50 U/ml penicillin/streptomycin (Lonza). 293FT-cells (Life Technologies Ltd) were cultured in the same conditions with 1% nonessential amino acids (NEAA, Cambrex, East Rutherford, NJ, USA). Plat-E-cells (Cell Biolabs, San Diego, CA, USA) and irradiated/mitomycin C (Sigma-Aldrich, St. Louis, MO, USA) treated mouse embryonic fibroblasts (MEF) (Millipore, Billerica, MA, USA) were maintained similarly but without antibiotics. iPSCs were sustained together with MEF feeder cells in KSR-medium containing knockout (KO)-DMEM (Life Technologies Ltd), 20% KO-serum replacement (KO-SR, Life Technologies Ltd), NEAA, glutamax, penicillin/streptomycin, 0.1 mM β-mercaptoethanol (Life Technologies Ltd), and 4 ng/ml basic fibroblast growth factor (bFGF, R&D Systems Inc., Minneapolis, MN, USA). All the cells were grown at 37 °C and 5% CO~2~ and the medium was changed every other day for iPSCs and two times a week for all the other cells.

2.3. Generation and characterization of iPSC lines {#s0040}
--------------------------------------------------

The LQT1 patients carried either the G589D mutation of *KCNQ1* (*KCNQ1*-FinA) or the ivs7-2A\>G mutation in *KCNQ1* (*KCNQ1*-FinB) [@bb0105]. Skin biopsies from the donors were cultured in 0.2% gelatin (Sigma-Aldrich)-coated flasks under fibroblast culturing conditions. iPSC lines were established using lentivirus infection followed by retrovirus infection. The full protocol has been described by Takahashi and colleagues[@bb0050]. Cells, plasmids and reagents used in this protocol include: 293FT cells, Plat-E cells, pLenti6/UbC/mSlc7a1-vector (Addgene, Cambridge, MA, USA), ViraPower™ Packaging Mix (Life Technologies Ltd), Lipofectamine™ 2000 (Life Technologies Ltd), Fugene 6 (Roche Diagnostics, Mannheim, Germany), and pMX retroviral vectors (hOCT3/4, hSOX2, hKLF4 and hc-MYC, all from Addgene). Several lines were established from both patients and from control individual and two from each were selected for further characterization. Studied cell lines were UTA.00208.LQT1 and UTA.00211.LQT1 generated from *KCNQ1* patient with G589D mutation, UTA.00102.LQT1 and UTA.00118.LQT1 generated from *KCNQ1* patient with ivs7-2A\>G mutation, and UTA.04602.WT and UTA.04607.WT generated from healthy control individuals.

Characterization of control iPSC lines is described in detail by Ahola and colleagues [@bb0110]. LQT1 specific iPSCs were characterized similarly by RT-PCR, immunocytochemistry, embryoid body (EB) and teratoma formation. Teratomas were generated from one control iPSC line (UTA.04602.WT) and two LQT1-lines one carrying G589D mutation and the other ivs7-2A\>G in *KCNQ1*. In addition, the karyotypes of all the lines were analyzed. The lines were also assayed with PCR and restriction reactions to detect the correct mutations of *KCNQ1* from the genomic DNA and the control iPSC line was verified not to carry these mutations. DNA was isolated using DNA Tissue XS-kit (Macherey-Nagel GmbH & Co., Düren, Germany) and multiplied with AmpliTaq 360 Polymerase (Life Technologies Ltd) with 100 ng of template, 2 mM of MgCl~2~, 200 μM of NTPs, 0.5 μM of primers (G589D forward: ttg act ctc agc tac ctc cc, reverse: tgc agg agc ttc acg ttc ac, ivs7-2A\>G forward: ggg gag ctg tag ctt cca ta, reverse: agc caa atg cat ggt gag at, Biomers.net GmbH, Ulm, Germany), and 1 U/ μl of enzyme in total volume of 40 μl. Reaction conditions: 96 °C for 10 min (96 °C for 30 s, 60 °C for 30 s, 72 °C for 2 min), 35 cycles, 72 °C for 5 min. Digestion for *KCNQ1*-G589D was done with HIN6I (Thermo Fisher Scientific, Inc., Waltham, MA, USA) with Tango Buffer (Thermo Fisher Scientific, Inc.), and for *KCNQ1*-ivs7-2A\>G with Dde1 (Thermo Fisher Scientific, Inc.) using FastDigest Buffer (Thermo Fisher Scientific, Inc.) both with 10 μl from PCR in total volume of 20 μl at 37 °C over night. Products were run on 4% agarose gel (EuroClone S.p.A., Milano, Italy): wild type (WT) for G589D (G589D-WT) generates product sizes 146, 82 and 39 bp, heterozygote (Hez) for G589D (G589D-Hez) generates an extra fragment of 185 bp, ivs7-2A\>G-WT produces sizes 228, 39 and 33 bp and ivs7-2A\>G-Hez an extra product with size of 261 bp. Extra fragments are caused by vanishing of the cleavage sites due to the mutations (G589D: 146 + 39 = 185, ivs7-2A\>G: 228 + 33 = 261) ([Fig. 2](#f0010){ref-type="fig"}).

2.4. Cardiac differentiation and immunocytochemical characterization of CMs {#s0045}
---------------------------------------------------------------------------

CM differentiation was accomplished by co-culturing iPSCs with END-2 cells (a gift from Prof. Mummery, Humbrecht Institute, Utrecht, The Netherlands). END-2 cells were cultured as described by Mummery and colleagues [@bb0115]. Differentiation was initiated by dissecting the undifferentiated iPSC colonies mechanically into aggregates containing a few hundred cells. These cells were then plated onto mitomycin C-treated END-2 cells in KSR medium without serum, serum replacement, or basic fibroblast growth factor but with 2.92 mg/ml of ascorbic acid [@bb0020] (Sigma-Aldrich). The cell colonies were monitored daily by microscopy, and the medium was changed after 5, 8, and 12 days. After 14 days of culturing, 10% serum replacement was added to the ascorbic acid free medium.

For immunocytochemical staining the beating areas of the cell colonies were cut with a scalpel and treated with collagenase A (Roche Diagnostics, Mannheim, Germany). Dissociated cells were plated on 0.1% gelatin-coated 24-well plate wells in KO-DMEM containing 20% FBS. A maximum of seven days after dissociation, beating cells were fixed with 4% paraformaldehyde (PFA, Sigma-Aldrich) for immunostaining with cardiac markers: anti-cardiac-troponin-T (1:1500, Abcam, Cambridge, MA, USA), anti-α-actinin (1:1500, Sigma-Aldrich), anti-myosin-heavy-chain (MHC, 1:100, Millipore), anti-ventricular-myosin-light-chain (MLC2v, 1:150, Abcam) and anti-atrial-myosin-light-chain (MLC2a, 1:300, Abcam). The secondary antibodies were Alexa-Fluor-568-donkey-anti-goat-IgG, Alexa-Fluor-568-goat-anti-mouse-IgG, Alexa-Fluor-488-donkey-anti-rabbit-IgG, and Alexa-Fluor-488-donkey-anti-mouse-IgG (all 1:800, all from Life Technologies Ltd).

2.5. Video recording {#s0050}
--------------------

For the video recordings CM aggregates were dissociated in the same way as for immunocytochemical analysis (see above). Videos were recorded within a week from dissociation using video microscopy (Nikon Eclipse TS100, Nikon Corporation, Tokyo, Japan) with a video camera Optika DIGI-12 (Optika Microscopes, Ponteranica, Italy). 30--60 second long monochrome videos were recorded with 720 × 480 resolution and 30 frames per second. Beating was determined as normal if the rhythm was regular and the phases of contraction and relaxation followed each other without any delay or additional movement of the cell. Any deviation from that was considered as abnormal beating.

2.6. Beating analysis {#s0055}
---------------------

In total 58 videos (13 controls, 24 LQT1-G589D (FinA)-specific and 25 LQT1-ivs7-2A\>G (FinB)-specific) were analyzed using digital image correlation (DIC) based analysis method, as described by Ahola et al. [@bb0110]. In brief, the velocity vector fields representing video image gray level changes in pixel level were calculated from subsequent video frames using a minimum quadratic difference based DIC method. For each CM, the beating focus point was visually determined and the CM was divided into 8 sectors, each comprising of 45° sector, around the beating focus point. With each selection, motion towards the beating focus point was determined as radial, and perpendicular motion as tangential movement. The sum radial and tangential components were computed for each sector.

Out of the 16 possible signals obtained from a CM 3 signals were selected based on the signal quality. From these signals the average parameters of beating were defined: (1) duration of the contraction, (2) time when contracted, (3) duration of the relaxation, (4) incomplete relaxation time and (5) time when relaxed.

2.7. Allelic imbalance {#s0060}
----------------------

Allelic discrimination between the WT and mutated *KCNQ1* alleles in CMs derived from different iPSC lines was done by qPCR using standard curves. In order to establish a *KCNQ1* allelic standard curves, the plasmid with WT *KCNQ1* and the plasmid containing the mutant allele were combined with following ratios: 1:0, 8:1, 4:1, 2:1, 1:1, 1:2, 1:4, 1:8 and 0:1, respectively, for the qPCR reactions [@bb0060]. The standard curves were done similarly for both mutations (G589D and ivs7-2A\>G) addressed in this study. Plasmids used for the curve preparation were pBluescript SK + plasmids (Addgene) with the inserted gene at the BamHI/NotI-site. The standard curves were plotted log~2~ of WT/mutant ratios of plasmids *versus* corresponding ΔCt values. The ΔCt values were defined by subtracting Ct value of WT allele from Ct value of the allele with the mutation. In standard curves, ΔCt values for plasmid ratios are represented in statistical form of mean ± standard deviation (n = 3) [@bb0090].

In addition, ΔCt values were defined for *KCNQ1* mutations and those were used for locate spots of *KCNQ1* mutated samples on plasmid-derived standard curves. The location of spot defines allelic imbalance of mutation when compared to nearby plasmid ratios.

To determine the allelic imbalance of *KCNQ1* in CMs originated from different mutation specific cell lines (UTA.00208.LQT1 with G589D, and UTA.00118.LQT1 containing ivs7-2A\>G) the clusters of beating areas were first cut using a scalpel and total RNA was purified from the cell clusters with a NucleoSpin® RNA II Kit (Macherey-Nagel GmbH & Co.) according to the manufacturer\'s protocol. The isolated RNA was converted into cDNAs using a High Capacity cDNA Reverse Transcription Kit (Life Technologies Ltd). For allelic discrimination the primers and probes were designed by Custom TaqMan® SNP Genotyping Assay service (Life Technologies Ltd). qPCR reactions were done using 7.5 μl 2 × TaqMan® Universal PCR Master Mix, 0.375 μl Custom TaqMan® SNP Genotyping Assay, and 2.125 μl sterile water with total volumes of 12 μl and 3 μl of cDNA or plasmid DNA added into the reaction. The program was initiated with 2 min at 50 °C and 10 min at 95 °C following 40 cycles of 15 s at 95 °C and 1 min at 60 °C.

2.8. Current clamp-measurements {#s0065}
-------------------------------

### 2.8.1. Potassium channel blockers {#s0070}

Rapid delayed rectifying potassium (I~Kr~ or hERG) channel blocker, N-\[4-\[\[1-\[2-(6-methyl-2-pyridinyl)ethyl\]-4-piperidinyl\]carbonyl\]phenyl\]methanesulfonamide dihydrochloride (E-4031 [@bb0120] Sigma-Aldrich) was dissolved in H~2~O (stock 2.11 mM) and stored at − 20 °C. I~Ks~ blocker, 2-(4-chlorophenoxy)-2-methyl-N-\[5 \[(methylsulfonyl)amino\]tricyclo\[3.3.1.13,7\]dec-2-yl\]-propanamide (JNJ303 [@bb0125] Tocris Bioscience, Bristol, United Kingdom) was dissolved in DMSO (stock 25 mM) and stored at − 20 °C. Experimental HEPES based perfusate with E-4031 and JNJ303 was freshly prepared on the day of use by dissolving the stocks to final concentrations of 100 nM and 300 nM (DMSO 0.03%), respectively. Action potentials (APs) were unaffected by a 0.03% DMSO vehicle tested in 5/5 CMs.

### 2.8.2. Measurement of action potentials {#s0075}

APs were recorded from spontaneously beating CMs in current-clamp mode using the perforated patch configuration [@bb0130] The HEPES based extracellular perfusate consisted of (in mM): 143 NaCl, 4.8 KCl, 1.8 CaCl~2~, 1.2 MgCl~2~, 5 glucose, and 10 HEPES, pH was adjusted to 7.4 with NaOH (at room temperature) and the osmolarity set to 308 ± 2 mOsm with sucrose (Gonotec, Osmomat 030, Labo Line Oy, Helsinki, Finland). The intracellular solution consisted of (in mM): 122 KMeSO~4~, 30 KCl, 1 MgCl~2~, and 10 HEPES. KOH was used to set pH to 7.15 and the osmolarity was set to 302 ± 2 mOsm. Amphotericin B (Sigma-Aldrich) was used as a membrane perforation agent and dissolved in DMSO to a final concentration in the patch pipette of 0.24 mg/ml. Dissociation of the spontaneously beating CMs was done similarly as for immunocytochemical staining and for video recordings but the cells were plated onto 0.1% gelatin-coated cover glasses of 5 mm⌀ for patch clamp-measurements. The CMs were recorded on days 6--7 after plating. Coverglasses with CMs were fast transferred to a preheated 36 ± 1 °C fast RC-24N perfusion chamber (Warner Instruments LLC, Hamden, CT, USA). An SH-27B inline heater (Warner Instruments LLC) was used to preheat the perfusate. Cells were rested in the extracellular perfusate for more than 10 min prior to patching. Patch electrodes (model PG150T, Harvard Apparatus, Holliston, MA, USA) were pulled with a PC-10 puller (Narishige International Limited, London, UK) and flame polished with microforge MF-900 (Narishige International Limited) to a resistance of 3.0--3.5 MΩ measured in the bath perfusate. Drugs were applied using a gravity controlled VC3 perfusion system (ALA Scientific Instruments, Farmingdale, NY, USA). APs were recorded in gap-free mode with pClamp 10.2 using the Axopatch 200B patch clamp amplifier connected to an acquisition computer *via* AD/DA Digidata 1440 (Molecular devices LLC). Current-clamp recordings were digitally sampled at 20 kHz and filtered at 5 kHz using the low pass Bessel filter on the recording amplifier. Numbers of CMs measured (n) are presented in the [Table 2A](#t0010){ref-type="table"}, [Table 2B](#t0015){ref-type="table"}, [Table 3A](#t0020){ref-type="table"}, [Table 3B](#t0025){ref-type="table"}.

### 2.8.3. Extraction of action potential characteristics {#s0080}

Following stabilization of the spontaneously generated APs in current-clamp mode, a baseline of minimum of 2 min was acquired before drug application. Gap-free traces of individual CM recordings were then imported into Microcal Origin™ 8.6 or 9.0 and processed by an automated script. Beats per minute (BPM), AP duration at 50% and 90% of repolarization (APD~50~ and APD~90~), AP amplitude (APA), and maximum diastolic potential (MDP) were extracted. dV/dT (V~max~, maximal upstroke velocity) was extracted from the differentiated time course traces as peak values corresponding to each single AP. Single AP characteristics were then plotted as a function of time for evaluation and a series of minimum of 15 APs were averaged for each CM and used in the statistical analysis. Ventricular-like CMs were defined by APD~90~/APD~50~ \< 1.3 and APA\>95 mV, atrial-like by APD~90~/APD~50~ \> 1.3 and APA\>95 mV and finally nodal-like were defined by APD~90~/APD~50~ \> 1.3 and APA \< 95 mV.

2.9. Combined current clamp-measurements and video analysis {#s0085}
-----------------------------------------------------------

APs from a CM of each cell line (control, G589D and ivs7-2A\>G) were recorded using a current clamp. During the current clamp-measurement, a concurrent video was recorded using an inverted IX71 microscope (Olympus Corporation, Hamburg, Germany) and an ANDOR iXon 885 CCD camera (Andor Technology, Belfast, Northern Ireland). The video recordings were then analyzed using the previously described method [@bb0110]. A good quality beating motion signal was selected, and the AP and the motion signal for each cell line were synchronized.

2.10. Calcium imaging {#s0090}
---------------------

CMs were dissociated as described in the section about immunocytochemical staining and plated onto 0.1% gelatin-coated 13 mm cover slips. 6--8 days after dissociation the cells were loaded with 4 μM Fura-2 AM (Life Technologies Ltd) for 30 min in HEPES based medium at 37 °C. After incubation the cover slips were moved to an RC-25 recording chamber (Warner Instruments LLC) and perfused with 36 ± 1 °C HEPES based solution (in mM): 137 NaCl, 5 KCl, 0.44 KH~2~PO~4~, 20 HEPES, 4.2 NaHCO~3~, 5 [d]{.smallcaps}-glucose, 2 CaCl~2~, 1.2 MgCl~2~ and 1 Na-pyruvate with pH adjusted to 7.4 with NaOH. Ca^2 +^-measurements were done with an inverted IX71 microscope and UApo/340 × 20 air objective (Olympus Corporation). Images were acquired with an ANDOR iXon 885 CCD camera (Andor Technology). A Polychrome V light source (15 nm bandwidth) and the camera were synchronized by an external DSP controller (TILL Photonics, Munich, Germany). TILLvisION software was used to acquire image data (TILL Photonics). Fura-2 in spontaneously beating cells was exited at 340 nm and 380 nm light and emission was detected at 505 nm and the data presented as ratios. The Ca^2 +^ handling was extracted for 15 s sweeps of spontaneous baseline beating and categorized into different rhythm categories based on the types of abnormalities observed: normal beating with stable amplitude (N), arrhythmias with double or more Ca^2 +^ peaks (AD), and arrhythmias with small amplitude Ca^2 +^ events between the stable amplitude Ca^2 +^ spikes (AS). A criterion for the AD group was a Ca^2 +^ spike with double or several peaks which do not reach the baseline. For the AS group the presence of a small amplitude Ca^2 +^ event of at least 10% of the preceding Ca^2 +^ spike amplitude was required. Numbers (n) of CMs measured were: for G589D specific cells the n = 87, for 7-2A\>G mutated the n = 80, and for control CMs the n = 45.

2.11. Statistical analysis {#s0095}
--------------------------

The variance between two experiments or more was calculated in Microcal Origin™ 9.0. Variance between two individual experiments was accessed using the two sample *t*-test and between more than two individual experiments the one-way ANOVA-test was used and followed by a Scheffe\'s post hoc-test. In drug experiments, the baseline and drug effect were compared using paired sample *t*-test. p \< 0.05 was considered significantly different and levels of significance are represented as (\*) p \< 0.05 and (\*\*) p \< 0.01. Data is shown as mean ± S.E.M. if not otherwise stated.

3. Results {#s0015}
==========

3.1. Pluripotency of the iPSCs {#s0100}
------------------------------

All the iPSC lines used in this study were verified for their pluripotency (control iPSCs have been characterized earlier [@bb0110]). Both control and LQT1-specific lines formed colonies typical for human pluripotent stem cells ([Fig. 1](#f0005){ref-type="fig"} A). The iPSCs also expressed markers for pluripotent state shown both by RT-PCT and immunocytochemistry ([Fig. 1](#f0005){ref-type="fig"} C and E), and the transgenes were silenced ([Fig. 1](#f0005){ref-type="fig"} B). *In vitro* pluripotency was shown by embryoid body (EB) formation ([Fig. 1](#f0005){ref-type="fig"} G) and *in vivo* by teratoma forming assay ([Fig. 1](#f0005){ref-type="fig"} F). All the lines were also verified for the normal karyotype ([Fig. 1](#f0005){ref-type="fig"} D).Fig. 1Pluripotency of iPSC lines. A: All the iPSC lines formed colonies typical for pluripotent stem cells. B and C: All the exogenous transgenes (Oct3/4, Sox2, Klf4 and c-Myc) were silenced (B) and endogenous markers for pluripotent state (Nanog, Sox2, Oct3/4 and Rex1) were expressed (C). β-Actin was used as a housekeeping gene. D: All the iPS cell lines had normal karyotype. E: Immunocytochemistry demonstrated the expression of pluripotency markers. F: Cell types derived from all three germ layers were found in teratomas. G: The expression of markers for the three germ layers was detected from EBs by RT-PCR.

3.2. Biochemical and genetic analysis of iPSC derived CMs {#s0105}
---------------------------------------------------------

The expression pattern of spontaneously single beating cells was typical for CMs exhibiting troponin T, α-actinin, myosin heavy chain (MHC), atrial specific myosin light chain (MLC2a) and ventricular myosin light chain (MLC2v). [Fig. 2](#f0010){ref-type="fig"} A--C depicts representative immunostainings of control ([Fig. 2](#f0010){ref-type="fig"} A), G589D ([Fig. 2](#f0010){ref-type="fig"} B) and ivs7-2A\>G ([Fig. 2](#f0010){ref-type="fig"} C) specific cell lines.Fig. 2Characterization of iPSC derived CMs. A--C: The CMs expressed cardiac-specific proteins. The scale bars refer to 100 μm. D--F: The LQT1-specific lines carried the correct mutations while no G589D or ivs7-2A\>G mutations were found in control cell lines. "A" in the figure refers to G589D mutation and "B" to ivs7-2A\>G. Control CMs produced products of 146 and 82 bp (and 39 bp, not shown in the figure) for G589D, and 228 bp-product (also fragments of 39 and 33 bp, not shown in the figure) for the region corresponding ivs7-2A\>G mutation (D). Heterozygous G589D specific lines (one shown in E) created an extra product of 185 bp and heterozygous ivs7-2A\>G lines had an extra product with the size of 261 bp (one in F). G and H illustrate the cleavage sites for the restriction enzymes used, their disappearance due to the mutations and the sizes of the products from the reactions for G589D (G) and ivs7-2A\>G (H).

The LQT1-specific lines were found to carry the correct mutations and these mutations were not found in control lines. This was determined by RT-PCR analysis and restriction enzyme digestion ([Fig. 2](#f0010){ref-type="fig"} D--F).

3.3. Mechanical properties of LQT1-specific CMs {#s0110}
-----------------------------------------------

We first visually analyzed the beating behavior of single CMs in videos obtained from the two control lines, the two G589D specific lines and the two ivs7-2A\>G specific lines. Control CMs used in the video analysis had a normal beating pattern (marginal irregularities, see below) with only contraction and relaxation phases following each other. However, with our two G589D specific lines we also observed a large proportion of abnormally beating cells with a prolonged phase of contracted state before relaxation. The two ivs7-2A\>G lines were also having a prolonged contraction/relaxation cycle. These cells typically had normal contraction but the relaxation phase was prolonged having vacillation before cells fully relaxed (see [Video 1](#ec0020){ref-type="supplementary-material"}, [Video 2](#ec0025){ref-type="supplementary-material"}, [Video 3](#ec0030){ref-type="supplementary-material"}).

Videos from control as well as LQT1-CMs with either of the mutations were analyzed in detail according to the displacement model illustrated in [Fig. 4](#f0020){ref-type="fig"} A (see also the [Methods](#s0010){ref-type="sec"} section). Representative signals from single CMs from both LQT1-specific cell lines (G589D or ivs7-2A\>G) as well as from control CM are presented in [Fig. 3](#f0015){ref-type="fig"} D--F. Normally beating control CMs (n = 13) comprised only of the phases 1 (contraction), 3 (relaxation) and 5 (relaxed) ([Fig. 4](#f0020){ref-type="fig"} B). However, in 17/24 CMs with G589D mutation, a prolonged contraction time was observed: They exhibited an additional phase 2 between contraction and relaxation phases, and during that phase the CMs stayed contracted. In a minor proportion (2/17) of G589D-CMs, a phase 4 (incomplete relaxation) was also found ([Table 1](#t0005){ref-type="table"}, [Fig. 4](#f0020){ref-type="fig"} C). CMs carrying the ivs7-2A\>G mutation also exhibited a prolonged contraction (phase 2, in 17/25), but the duration of the phase 2 was not as prominent as in G589D-CMs. Instead, ivs7-2A\>G-CMs typically had rather normal contraction, but the relaxation was abnormal and prolonged (in 15/17 CMs) due to vacillation (incomplete relaxation, phase 4, [Table 1](#t0005){ref-type="table"}, [Fig. 4](#f0020){ref-type="fig"} D). The time durations of different phases in control CMs and in CMs with the two LQT1 specific mutations are summarized in [Table 1](#t0005){ref-type="table"}. There was some overlap in the abnormal beating behavior between the two mutations: However, only 12% (2/17) of the cells with G589D failed to relax normally, but 88% (15/17) of the cells with ivs7-2A\>G demonstrated some prolongation in the contraction phase (phase 2). Beating patterns comparable to controls were also observed in CMs with G589D (n = 7/24, 29%) or ivs7-2A\>G (n = 8/25, 32%).Fig. 3ECGs of the donors and functionality of iPSC derived CMs. A--C: ECGs from the primary cell donors. D--F: Video recording analysis of control (D), G589D (E) and ivs7-2A\>G (F)-specific CMs. Contraction is indicated with downward peak and the upward peak refers to relaxation. Bars (E) indicate the phase 2 (see [Fig. 4](#f0020){ref-type="fig"} A) and show the time when the CMs stayed contracted and the highlighted areas (F) refer to the time of incomplete relaxation (phase 4 in [Fig. 4](#f0020){ref-type="fig"} A). G--I: Ventricular APs from control CMs (G) and LQT1-specific CMs carrying G589D (H) or ivs7-2A\>G (I). J--L: Ca^2 +^-imaging signals from control (J) and LQT1-specific CMs (K, L). The most prevalent type of abnormal Ca^2 +^ transients in ivs7-2A\>G-specific CMs was additional small Ca^2 +^ transients (AS) (L, extra peaks marked with arrows) but in G589D CMs double or more Ca^2 +^ peaks (AD) (K) in addition to AS were seen.Fig. 4Analysis of LQT1-CMs using digital image correlation. A: An artificial illustration of a beating signal. 1: time of contraction (phase 1), 2: time in contracted state (phase 2), 3: time of relaxation (phase 3), 4: time of incomplete relaxation (phase 4), and 5: time in relaxed state (phase 5) (see phases also in [Table 1](#t0005){ref-type="table"}). The same colors and patterns are used in panels B--G. B: Beating pattern of control CMs. C: Beating pattern of G589D-CMs. D: Beating pattern of ivs7-2A\>G-CMs. The cells are presented in order of beating rate: control CMs: 12--66 beats/min, G589D-CMs: 8--62 beats/min and ivs7-2A\>G-CMs: 9--45 beats/min. E--G: The time duration from the beginning of contraction to the beginning of relaxation and from the beginning of relaxation to the beginning of contraction are presented. Contraction time was in the range of 0.25--0.5 s in control CMs (E). In LQT1-CMs the contraction time was longer or incomplete relaxation was present (F and G). The points for contraction time are enlarged to highlight the differences in the contraction times between control CMs and LQT1 specific CMs (a point with a value of 1.75 ms in G589D-figure is not included).Table 1The average times (ms) and standard mean errors for each individual beating phase and the total sum of the phases. Phase 1 is the time of contraction, phase 2 refers to the time when the cells stay contracted, phase 3 is the relaxation time, and phase 4 indicates the time of incomplete relaxation. The time when the cells are relaxed (phase 5) is not displayed in the table. (\*) indicates p \< 0.05 and (\*\*\*) indicates p \< 0.001 (one-way ANOVA) for abnormal G589D-CMs vs. control CMs and vs. abnormal ivs7-2A\>G-CMs concerning the phase 2. For abnormal ivs7-2A\>G-CMs vs. abnormal G589D-CMs (two sample t-test) in the case of the phase 4 (\*) also indicates p \< 0.05 and (\*\*\*) indicates p \< 0.001. Data is presented as mean ± S.E.M. The abnormal behavior of the cells is highlighted with bold.BPMPhase 1Phase 2Phase 3Phase 4Sum P 1--4*Control*Normal n = 1129.3 ± 4.4\*\*294.3 ± 31.94.7 ± 1.9426.0 ± 41.9N/A725.0 ± 70.2Abnormal n = 0N/AN/AN/AN/AN/AN/A  *G589D*Normal n = 733.2 ± 6.5275.9 ± 19.215.5 ± 5.7362.0 ± 19.30.0 ± 0653.4 ± 27.5Abnormal n = 1723.6 ± 3.6285.2 ± 26.3**180.8 ± 28.8\***\
(n = 17/17)365.1 ± 29.1**37.3 ± 36.7**\
(n = 2/17)868 ± 74.8  *ivs7-2A\>G*Normal n = 830.6 ± 5.7248.2 ± 31.15.0 ± 2.9383.0 ± 48.00.0 ± 0636.3 ± 79.0Abnormal n = 1725.2 ± 2.3318.7 ± 39.9**46.3 ± 13.6**\
(n = 15/17)424.8 ± 44.4**366.7 ± 66.9\*\*\***\
(n = 17/17)1156.4 ± 123.0

When the absolute time of contraction (phases 1 and 2), relaxation (phases 3 and 5) and incomplete relaxation (phase 4) was plotted against the beating frequency the contraction time for the control cell population ([Fig. 4](#f0020){ref-type="fig"} E) stayed at the range of 0.25--0.5 s corresponding the contraction time of human heart [@bb0135]. The relaxation time increased with a decreased beating rate also resembling the behavior of human heart. The abnormally beating LQT1-CMs presented contraction times of up to 0.75 s, while the contraction times of the control cells were less than 0.5 s (a not statistically significant difference, one-way ANOVA). If incomplete relaxation (phase 4) was added to the contraction time, the total times when the cells were not relaxed, were even more different from the times observed in normally beating cells although the difference was still not statistically significant ([Fig. 4](#f0020){ref-type="fig"} F and G). The normally beating LQT1-CMs resembled control CMs regarding their contraction-relaxation properties ([Supplementary Fig. 1](#ec0010){ref-type="supplementary-material"}).

3.4. Allelic imbalance in patient specific cells {#s0115}
------------------------------------------------

The allelic discriminations between the WT and mutated *KCNQ1* alleles in CMs specific for either G589D or ivs7-2A\>G mutation were determined. The expression ratio between the WT and the G589D-*KCNQ1* was found to be 4:1 (WT:mutated) in both LQT1-G589D cell lines ([Supplementary Fig. 2](#ec0015){ref-type="supplementary-material"}). For the *KCNQ1*-ivs7-2A\>G mutation the discovered ratio was 3:1 (WT:mutated) ([Supplementary Fig. 2](#ec0015){ref-type="supplementary-material"}).

3.5. Electrical properties of LQTS-specific CMs {#s0120}
-----------------------------------------------

### 3.5.1. Baseline characteristics {#s0125}

Representative APs from ventricular CMs (both G589D and ivs7-2A\>G-specific) as well as from control CM are presented in [Fig. 3](#f0015){ref-type="fig"} G--I. The majority of the CMs recorded were ventricular-like and only a marginal proportion was nodal-like ([Table 2A](#t0010){ref-type="table"}). As expected, the APDs were significantly prolonged in nodal-, atrial- and ventricular-like LQT1-CMs compared to the control CMs ([Fig. 5](#f0025){ref-type="fig"} D, ANOVA, p \< 0.05). MDPs for atrial- and ventricular-like CMs were recorded from − 65 mV to − 82 mV with overshoots of around + 40 mV. In contrast, nodal-like CMs were more depolarized and around − 66 mV with overshoots less than + 25 mV ([Table 2A](#t0010){ref-type="table"}).Fig. 5Current clamp-recordings from control and LQT1-CMs carrying either G589D or ivs7-2A\>G. Beating CMs un-patched (A), patched in relaxed phase (B), and patched in contracted phase (C). Arrows indicate the positions where the contraction can be seen (C). D: Current clamp-recordings of ventricular-, atrial- and nodal-like APs are depicted for control (upper panel), G589D (middle panel) and ivs7-2A\>G (lower panel)-CMs. E: Baseline characteristics of spontaneous APs with early after depolarizations (EADs) in G589D-specific CMs: dashed line represents 0 mV and arrows indicate EADs. The effects of JNJ303 (F), and E-4031 (G) are shown for ventricular-like AP recordings from controls, as well as from G589D and ivs7-2A\>G-CMs. Baseline (1), (2) effect of I~Ks~ (JNJ303) or I~Ks~ (E-4031) blocker, and (3) wash out measurement which fully recovers the effect of JNJ303 but only partially reverses the baseline AP characteristics after the E-4031 treatment. Arrows indicate EADs. The right panels show the time courses for the overshoot (Max), MDP, APD~90~ and APD~50~. Marks (1), (2) and (3) indicate the times of AP extraction, and the bar represents the exposure of the cells for JNJ303 or E-4031.Table 2ABaseline characteristics of spontaneous action potentials (APs) from control cardiomyocytes (CMs) as well as from LQT1-G589D- and LQT1-ivs7-2A\>G-specific CMs. (\*) indicates significance levels of p \< 0.05 and (\*\*) p \< 0.01. Significance levels were obtained by one-way ANOVA of grouped data from nodal, atrial and ventricular CMs, respectively. Data is presented as mean ± S.E.M. CMs with baseline arrhythmia are not included (see [Table 2B](#t0015){ref-type="table"}).Number of cells\
\[n (%)\]BPMAPD~50~\
(ms)APD~90~\
(ms)APA\
(mV)MDP\
(mV)V~max~\
(dV/dT)*Control*Nodal-like2 (6.7)75.7 ± 4.4104.4 ± 2.1159.1 ± 0.488.7 ± 0.6− 66.0 ± 0.38.70 ± 2.3Atrial-like4 (13.3)61.5 ± 8.5132.6 ± 13.6189.1 ± 32.2100.4 ± 3.0− 71.6 ± 3.426.1 ± 17.9Ventricular-like24 (80.0)55.6 ± 3.4291.8 ± 21.5349.6 ± 22.9110.2 ± 2.4− 69.6 ± 1.519.5 ± 4.7  *LQT1 (G589D)*Nodal-like2 (5.1)54.5 ± 4.1164.5 ± 6.2\*309.2 ± 39.7\*83.4 ± 3.7− 63.6 ± 1.74.2 ± 7.1Atrial-like12 (30.8)38.9 ± 4.5335.7 ± 36.2\*\*477.7 ± 51.4\*\*106.4 ± 2.8− 70.5 ± 2.023.9 ± 6.9Ventricular-like25 (64.1)37.7 ± 4.6\*458.5 ± 57.4\*\*545.3 ± 62.6\*\*109.0 ± 3.1− 73.6 ± 1.614.8 ± 1.8  *LQT1 (ivs7-2A\>G)*Nodal-like2 (6.1)69.4 ± 6.0170.5 ± 17.3232.1 ± 7.7\*93.0 ± 1.3− 61.0 ± 9.69.5 ± 1.5Atrial-like6 (18.2)50.9 ± 9.9187.8 ± 15.0\*287.8 ± 18.5\*101.2 ± 2.2− 66.0 ± 2.616.3 ± 4.2Ventricular-like25 (75.7)45.6 ± 2.8\*416.1 ± 22.1\*\*481.5 ± 23.6\*\*115.1 ± 1.3− 72.3 ± 1.016.2 ± 2.4

In the G589D-specific CMs, but not in controls or in ivs7-2A\>G-specific CMs, spontaneous baseline early afterdepolarizations (EADs) were observed in 16.7% (5/30) of ventricular-like CMs ([Fig. 5](#f0025){ref-type="fig"} E, [Table 2B](#t0015){ref-type="table"}). These CMs with baseline EADs were not used in the drug studies. Nevertheless, in these cells with spontaneous EADs we found a consistent elevation of the APD~90~/APD~50~ ratios (\> 1.8) compared to baseline ratios without EADs (\< 1.3). The ratio prolongation is due to the presence of EADs evoking around − 25 mV, and thereby prolonging only the APD~90~ value (see [Fig. 5](#f0025){ref-type="fig"} E).Table 2BBaseline characteristics for G589D-CMs with EADs. Data is presented as mean ± S.E.M.Number of cells\
(n)BPMAPD~50~\
(ms)APD~90~\
(ms)APA\
(mV)MDP\
(mV)V~max~\
(dV/dT)LQT1 (G589D) Ventricular-like530.1 ± 4.4820.3 ± 93.11559.6 ± 407.1112.8 ± 3.8− 71.5 ± 2.712.7 ± 2.3

### 3.5.2. Effect of JNJ303 and E-4031 {#s0145}

Ventricular-like CMs were exposed to the I~Ks~ blocker, JNJ303 (300 nM) and APs from the baseline, in the presence of JNJ303 and after wash out was extracted ([Fig. 5](#f0025){ref-type="fig"} F). In control CMs (n = 10), JNJ303 significantly prolonged APD~50~ and APD~90~ by a similar proportion of 31% and 28%, respectively, but other AP characteristics were unaffected ([Table 3A](#t0020){ref-type="table"}). However, the effect of JNJ303 was only marginal on the APD~50~ and APD~90~ in G589D-specific cells (prolongation of 7.7% and 8.7%, respectively, [Fig. 5](#f0025){ref-type="fig"} F, middle panel), and in ivs7-2A\>G-specific CMs no effects were observed ([Table 3A](#t0020){ref-type="table"}, [Fig. 5](#f0025){ref-type="fig"} F, lower panel). The effect of JNJ303 was fully reversible following the wash out, and the beating frequency was not significantly affected. In a few cells from each group the JNJ303 block was verified by a consecutive application, which always was similar to the first ([Fig. 5](#f0025){ref-type="fig"} F, LQT1-G589D). The APD~90~/APD~50~ ratios for the control, G589D-specific- and ivs7-2A\>G-specific CMs at baselines and in the presence of JNJ303 were similar and found to be between 1.19--1.27.Table 3AEffect of I~Ks~ block on ventricular-like cardiomyocytes (CMs). Statistical difference of *paired sample t-test* is indicated by (\*) p \< 0.05 and (\*\*) p \< 0.01. Data is presented as mean ± S.E.M.Number of cells\
(n)BPMAPD~50~\
(ms)APD~90~\
(ms)APA\
(mV)MDP\
(mV)V~max~\
(dV/dT)*Control*Baseline1048.3 ± 8.4264.7 ± 47.0334.0 ± 30.1103.6 ± 3.9− 69.0 ± 2.525.3 ± 10.4300 nM JNJ30342.8 ± 7.6\*346.6 ± 68.0\*\*428.2 ± 79.9\*\*106.3 ± 4.6− 69.7 ± 2.627.8 ± 12.3  *LQT1 (G589D)*Baseline944.7 ± 5.5393.0 ± 57.8500.4 ± 76.0108.3 ± 3.1− 71.9 ± 2.611.6 ± 2.6300 nM JNJ30338.7 ± 5.2423.6 ± 64.4544.0 ± 86.0106.9 ± 2.8− 70.8 ± 2.310.9 ± 2.1  *LQT1 (ivs7-2A\>G)*Baseline644.5 ± 3.2387.0 ± 49.3458.1 ± 51.6112.4 ± 4.2− 74.2 ± 2.69.8 ± 1.9300 nM JNJ30343.1 ± 4.6386.0 ± 36.0452.0 ± 37.9111.1 ± 3.6− 72.0 ± 3.19.8 ± 1.9

To evaluate our I~Ks~ findings we also applied the I~Kr~ (hERG) blocker, E-4031 (100 nM) on ventricular-like CMs. The effect of E-4031 from three representative current-clamp recordings is shown in [Fig. 5](#f0025){ref-type="fig"} G. In control cells the APD~50~ and APD~90~ were prolonged by E-4031 (30% and 74%, respectively), and the APD~90~/APD~50~ ratio was now increased from 1.21 (baseline) to 1.67 (E-4031) but no EADs were evoked ([Fig. 5](#f0025){ref-type="fig"} G, upper panel, [Table 3B](#t0025){ref-type="table"}). In contrast, all ventricular-like CMs in the G589D-specific group (5 cells) and in the ivs7-2A\>G-specific group (7 cells) exhibited EADs when exposed to E-4031 ([Fig. 5](#f0025){ref-type="fig"} G, middle and lower panel, respectively). The G589D-CMs had APD~50~ and APD~90~ significantly prolonged by 70% and 318% (paired sample *t*-test), respectively, and ADP~90~/APD~50~ ratios were found to be increased from 1.16 (baseline) to 2.18 (E-4031). In the CMs with ivs7-2A\>G, APD~50~ and APD~90~ were even more significantly prolonged by 412% and 771% (paired sample *t*-test), respectively, and ADP~90~/APD~50~ ratios were found to be increased from 1.14 (baseline) to 2.09 (E-4031). In contrast to the effects of JNJ303, E-4031 decreased the beating frequency of all CMs (paired sample *t*-test). All CMs tested with E-4031 became significantly depolarized during exposure (paired sample *t*-test), but the overshoot (peak) was not affected by E-4031 ([Fig. 5](#f0025){ref-type="fig"} G, [Table 3B](#t0025){ref-type="table"}). Even though APDs nearly recovered following wash out the, MDPs recovered only partially ([Fig. 5](#f0025){ref-type="fig"} G, right panels) after exposure to E-4031. In line with this, the beating frequency increased following the wash out (data not shown).Table 3BEffect of I~Kr~ block on ventricular-like CMs. Ventricular-like LQT1-specific CMs all showed early after-depolarizations (EADs) in the presence of E-4031. Statistical difference of *paired sample t-test* is indicated by (\*) p \< 0.05, (\*\*) p \< 0.01 and (\*\*\*) p \< 0.001. Data is presented as mean ± S.E.M.Number of cells\
(n)BPMAPD~50~\
(ms)APD~90~\
(ms)APA\
(mV)MDP\
(mV)V~max~\
(dV/dT)*Control − EADs*Baseline568.8 ± 4.3256.8 ± 30.4308.0 ± 30.1111.4 ± 3.5− 74.6 ± 3.610.1 ± 1.4100 nM E-403160.2 ± 7.6332.4 ± 82.5535.3 ± 102.9\*83.3 ± 7.5\*\*− 52.1 ± 1.5\*\*6.2 ± 1.8  LQT1 (G589D) + EADsBaseline543.2 ± 3.5458.6 ± 25.1536.0 ± 33.8114.6 ± 0.4− 81.1 ± 0.913.7 ± 2.9100 nM E-403123.5 ± 4.4\*781.7 ± 16.2\*\*\*1703.8 ± 100.8\*\*103.6 ± 1.7\*− 70.7 ± 2.9\*9.3 ± 1.5\*  LQT1 (ivs7-2A\>G) + EADsBaseline742.5 ± 3.4464.7 ± 49.3526.1 ± 53.6117.5 ± 1.4− 73.6 ± 1.814.1 ± 0.9100 nM E-403113.8 ± 2.6\*\*\*1915.7 ± 468.8\*4055.8 ± 1173.1\*109.7 ± 2.6\*\*− 64.1 ± 2.7\*\*11.3 ± 1.0\*\*

3.6. Comparison of the electrical and mechanical phenotypes {#s0130}
-----------------------------------------------------------

The mechanical analysis was also conducted together with the current clamp-measurements ([Fig. 6](#f0030){ref-type="fig"}). Thereby the mechanical and electrophysiological phenotypes could be compared and the timing of the electrical activity and the contraction/relaxation of the cells could be evaluated. In both cell types, control CMs ([Fig. 6](#f0030){ref-type="fig"} A) and LQT1 specific CMs ([Fig. 6](#f0030){ref-type="fig"} B), the AP was immediately followed by the contraction. In LQT1 specific CMs the APD was clearly prolonged and the mechanical abnormality correlated nicely with this prolongation ([Fig. 6](#f0030){ref-type="fig"} B). Also, the mechanical activity of the LQT1 specific cells seemed to continue longer after the electrical activity had already stopped when compared to control CMs.Fig. 6Combined current clamp-measurements and video analysis. Control CMs (A) as well as the LQT1 specific CMs (B) showed a nice correlation in timing of the contraction and the AP: Contraction followed immediately after the initiation of AP. In LQT1 specific CMs the APD was clearly prolonged compared to the control cells and the mechanical abnormality observed by video analysis correlated with the prolongation of the APD (B).

3.7. Ca^2 +^ handling of LQT1-specific CMs {#s0135}
------------------------------------------

To further study the functionality of LQT1 specific CMs, Ca^2 +^ transients were measured during spontaneous baseline beating. In G589D and ivs7-2A\>G specific as well as in controls three major responses were found. A robust beating pattern with stable Ca^2 +^ amplitude and frequency were characteristic for the majority of the control CMs (N), while arrhythmias with double or more Ca^2 +^ peaks (AD) or arrhythmias with small amplitude Ca^2 +^ events between the stable amplitude Ca^2 +^ spikes (AS) were frequently seen in G589D and ivs7-2A\>G CMs ([Fig. 7](#f0035){ref-type="fig"} A, Supplementary Table 1). Both types of arrhythmias (AD and AS) were seen in all cell types though the Ca^2 +^ transient abnormalities were more prevalent in both LQT1 specific cell lines compared to control CMs ([Fig. 7](#f0035){ref-type="fig"} B). The cells with G589D had the highest proportion of ADs (23%). The duration of the calcium elevation was significantly longer in CMs with G589D exhibiting ADs compared to those showing AS type of arrhythmia or normal beating (p \< 0.01, one-way ANOVA). AS-arrhythmia were also more pronounced in CMs with G589D resulting in significantly lower beating frequency (p \< 0.02, one-way ANOVA). Representative Ca^2 +^ signals from single CMs from both LQT1-specific cell lines (G589D or ivs7-2A\>G) as well as from control CM are shown in [Fig. 3](#f0015){ref-type="fig"} J--L.Fig. 7Analysis of Ca^2 +^ transients of control and LQT1 specific CMs. (A) Three different transient categories: normal transients with stable amplitude (N), arrhythmias with double or more Ca^2 +^ peaks (AD), and small amplitude Ca^2 +^ events (arrows) (AS) were found. (B) Doughnut charts indicate the percentage of the control and LQT1 specific CMs under each transient category (N, AD and AS).

4. Discussion {#s0020}
=============

In the present study we analyzed LQT1-specific CMs carrying either G589D or ivs7-2A\>G mutation in the *KCNQ1* gene. The LQT1-CMs with either mutation had prolonged AP durations. EADs were spontaneously present only in CMs with G589D mutation but not with ivs7-2A\>G mutation. However, EADs could be evoked pharmacologically in CMs with either mutation. In control CMs EADs were absent at baseline and they could not be induced with I~Ks~ or I~Kr~ blockers. Ca^2 +^ transients were also aberrant in both types (G589D and ivs7-2A\>G) of LQT1-CMs having large double spikes or extra spikes with small amplitude. In control CMs contraction and relaxation happened fast with no pause in-between. However, this beating behavior in LQT1-CMs was clearly abnormal. Using video recording analysis, LQT1-specific CMs were found to exhibit two distinct forms of abnormal mechanical beating behavior: CMs carrying G589D mutation typically stayed contracted for prolonged time while CMs with ivs7-2A\>G mutation showed an incomplete relaxation phase.

Our current clamp data demonstrates that the APDs measured from LQT1-CMs with either of the mutations (G589D or ivs7-2A\>G) were significantly prolonged. Heterozygous expression of the G589D and ivs7-2A\>G mutations in non-cardiac cells has earlier shown that both mutations have a dominant negative effect in gene expression systems [@bb0035], [@bb0140], although the expression of G589D mutation did not lead to altered current density, the cAMP induced up-regulation of I~Ks~ was abolished by the mutation [@bb0140]. The ivs7-2A\>G mutation on the other hand, almost completely abolished the I~Ks~ current when transiently expressed in non-cardiac cells [@bb0035]. The lack of I~Ks~ reduction in the G589D transfected non-cardiac cells may be due to trafficking problems caused by G589D: the mutated protein does not reach the cell surface [@bb0045]. The effect of G589D in LQTS has also been explained by disrupted β-adrenergic activation of I~Ks~ [@bb0145] but this study clearly shows that the disease phenotype caused by G589D is not solely dependent on central nervous system and activation of β-adrenergic receptor since it is present also in single dissociated CMs.

As mentioned, baseline-APDs were significantly prolonged in LQT1-CMs compared to the control CMs. With LQT1-CM we could further detect that ventricular-like CMs were only marginally affected or completely unaffected by I~Ks~ blockage. The lack of effect of I~Ks~ blockade in our LQT1-CMs is in accordance with the previous observation that the baseline I~Ks~ current is decreased by about 75% in LQT1-CMs [@bb0090]. In our study, G589D-CMs had longer baseline-APD~90~ than ivs7-2A\>G-CMs and spontaneous EADs were observed only in G589D-CMs, but none in CMs with ivs7-2A\>G nor in control CMs. However, the APD prolongation with I~Kr~ blockage always evoked EADs in both types of LQT1-specific CMs but not in control CMs. The I~Kr~ block also induced a depolarization of the baseline as previously shown [@bb0150].

CMs carrying either one of the LQT1 mutations demonstrated abnormalities in intracellular Ca^2 +^ transients, but the abnormal features were more common in G589D mutated CMs similarly as these CMs had more severe abnormalities in current clamp analysis. Abnormal Ca^2 +^ transients could be occasionally observed also in control CMs (6% of the cells), but at least third of the LQT1-CMs presented Ca^2 +^ abnormalities. In LQTS-CMs, EADs have been thought to result from late membrane-inward currents, such as the spontaneous reactivation of the L-type Ca^2 +^-channel during prolonged action potential duration [@bb0155]. Therefore it can be assumed that abnormalities in Ca^2 +^ transients shown in this study may correspond to EADs and lead to severe arrhythmias. A similar finding has been also earlier observed and demonstrated combining patch clamp and Ca^2 +^-imaging methods [@bb0160]. Further studies are needed to clarify the mechanism of the different Ca^2 +^ transients observed in our study and their correlation with the EADs as well as with the motion abnormalities observed with the two different LQT1 related mutations.

In addition to conventional methods (patch clamp and Ca^2 +^-imaging), we also analyzed the mechanical beating behavior of single LQT1-specific CMs by video imaging and this analysis revealed either prolonged contraction (G589D) or disturbed relaxation (ivs7-2A\>G) of the cells. This abnormality has not been reported earlier in iPSC-derived LQTS specific CMs, but the observation is in line with a clinical observation of prolonged contraction duration in LQTS mutation carriers compared to healthy individuals [@bb0165]. In this study, combined current clamp-measurements and video analysis of the mechanical behavior demonstrated the correlation between the prolonged APD and abnormal mechanical phenotype also in single LQT1 specific CMs.

The two patients of this study are both heterozygous for the LQT1-mutations and the allelic discrimination study revealed an imbalance in the expression of the WT and mutated forms of *KCNQ1*. The ratio of expression (WT:mutated) for G589D was found to be 4:1 and for ivs7-2A\>G the ratio was 3:1. It was reported earlier that LQT1-CMs with R190Q mutation exhibited equal expression of wild type and mutant alleles [@bb0090]. With the expression ratios observed in our study, the probability that one or more mutated α-subunits are participating in forming the tetrameric I~Ks~ channel is about 70%. This is in accordance with the functional abnormalities observed in the videos recorded from our CMs. Ca^2 +^-imaging also revealed abnormal Ca^2 +^ transients in LQT1 CMs but the proportions of abnormal CMs were slightly lower than those obtained with video imaging. The presence of spontaneous EADs were, however, considerably lower than other abnormalities. It is possible that there are compensatory mechanisms involved in electrical data obtained by patch clamp, resulting in a lower frequency of abnormalities compared to other methods. It is also important to point out that the ratios obtained by allelic imbalance measurements reflect the situation at mRNA level and do not accurately depict the proportions of the two alleles expressed at protein level since the transcripts may be alternatively processed before translation into proteins. Further, there is a possibility that the expression ratio of the WT and mutated allele may vary from cell to cell. It is also possible that the cells with different beating properties could represent also a particular CM subpopulation (ventricular, atrial or nodal).

Our findings support the previous studies [@bb0020], [@bb0030] suggesting that mutations in different parts of the *KCNQ1* gene are associated with different clinical outcomes. However, no clinically distinct differences between the patient groups carrying the two mutations presented in this study have been reported. QTc of G589D-carriers has been reported to be 462 ± 38 if recorded from patients without any medication at the time of ECG recording. For the ivs7-2A\>G the corresponding QTc value has been reported to be 470 ± 31 [@bb0105]. Both patients investigated here were symptomatic. G589D-patient, 46-year-old female has been suffering from syncopal spells. The other patient, 51-year-old female carrying ivs7-2A\>G in *KCNQ1*, has suffered from dizziness, darkening of vision and more recently also from episodes of unconsciousness. On cell level G589D-CMs demonstrated more severely prolonged APDs which could be visualized as prolonged contracted state in beating CMs. The ivs7-2A\>G-CMs had less severe APD prolongation at baseline, but they were more sensitive to agents blocking other ion channels. Additionally their beating behavior presented problems in relaxation phase suggesting other, currently unknown problems in repolarization currents in these cells. Since the patients present clinically similar phenotypes, it is most likely that there are some compensatory elements influencing the intact heart which moderate the clinical outcome. The highly organized transverse (t)-tubule structures in ventricular myocardium might partially balance the abnormalities in the Ca^2 +^ transients of G589D and ivs7-2A\>G-CMs [@bb0170]. At the same time, it is also possible that the typical abnormality that we observed in G589D-cells, namely prolonged contraction time, could actually generate more severe symptoms due to a shortened relaxation time.

This is the first time that two different LQTS related mutations in the same gene are reported to result in differences in functional properties of the patient specific CMs. Additionally, this is the first report to demonstrate abnormal mechanical beating properties of LQTS-specific single CMs. Earlier, the mechanical abnormalities with increased diastolic phase have been reported at the level of a whole heart of LQTS patients [@bb0165] but the abnormal mechanical phenotype in LQTS specific single cells is a novel and rather unexpected finding. Here we demonstrate that the disease specific beating of the cells can be distinguished from the normal behavior of single CMs just by analyzing the mechanical features of the beating. This novel method for characterization of CMs may generate additional detailed information from the beating of the cells and also from LQTS in general. In addition, this simple detection method allows developing it further for high through-put screening for LQTS specific -- and also other cardiac disease specific -- CMs.

5. Conclusion {#s0025}
=============

CMs derived from two symptomatic LQT1 patients carrying two different *KCNQ1* mutations presented different manifestations when their electrical or mechanical beating properties were analyzed. APDs were significantly prolonged in both types of LQT1-CMs, but spontaneous EADs were present only in G589D-CMs. Mechanical beating behavior of G589D-CMs presented mostly prolonged contraction phase while inv7-2A\>G-CMs had a fairly normal contraction time, but failed to relax properly. These results also demonstrate that simply by analyzing the mechanical beating behavior of the cells, the diseased CMs can be distinguished from the normal ones, providing a simple platform for diagnostic applications using iPSC derived CMs in the future.

The following are the supplementary data related to this article.Supplementary material.Supplementary Fig. 1Analysis of the beating properties of normally beating LQT1 specific CMs using digital image correlation (DIC). A: The proportional phases of beating for 7 single CMs carrying G589D (FinA) mutation in *KCNQ1* and still behaving as control cells in regard to their mechanical properties. B: The proportional phases of beating for 8 LQT1 specific normally beating CMs with ivs7-2A\>G (FinB) in *KCNQ1* are presented here. See the artificial illustration of a beating signal showing the characteristics measured from the cells in [Fig. 4](#f0020){ref-type="fig"} A. C: The contraction/relaxation-diagram for the CM population behaving like control cells and still carrying LQT1 related mutation (G589D) in KCNQ1. The contraction time of these cells was in the range of 0.25--0.5 s. Panel D of the figure presents the same contraction/relaxation-diagram for the normally beating CMs with ivs7-2A\>G mutation. Enlarged figures (C and D) emphasize the contraction times which all were less than 0.5 s. The cells in A and B are presented in beating order ranging from 16 to 63 and from 9 to 57 in G589D and ivs7-2A\>G-specific CMs, respectively.Supplementary Fig. 2Allelic discriminations between the WT and mutated *KCNQ1* alleles in LQT1 specific CMs. The expression ratio of the WT- and the G589D-*KCNQ1* was 4:1 (WT/mut) (A) and this was confirmed using two different G589D specific cell lines (UTA.00208.LQT1 and UTA.00211.LQT1). For the *KCNQ1*-ivs7-2A\>G mutation the ratio was 3:1 (WT/mut) (B) which was shown only with one cell line (UTA.00118.LQT1) carrying ivs7-2A\>G but the result was repeated in three different experiments.Video 1An example of the beating of control cardiomyocytes (CMs). The video here show how the control CMs beat regularly without any additional movement of the cells besides the continuous contraction and relaxation.Video 2Cardiomyocytes (CMs) carrying LQT1 related G589D mutation (FinA) in *KCNQ1*. The CMs with G589D mutation typically exhibit a prolonged contraction phase which is seen in this video. The cells seem to be unable to relax upon contraction but instead the relaxation occurs after a prolonged contraction phase.Video 3An example of the beating of cardiomyocytes (CMs) with ivs7-2A\>G (FinB) mutation in *KCNQ1*. The CMs carrying LQT1 related ivs7-2A\>G mutation typically have problems during the relaxation phase, as seen in the video here. These cells seem to vibrate or vacillate before or during the relaxation phase or alternatively tremble upon they have been relaxed (incomplete relaxation).
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